President Biden's executive order to increase access to contraception
In the USA, President Joe Biden will be signing an executive order to expand access to contraception.
The order comes after concerns have been raised about the security of access to contraception since bans on abortion have come into play and the Supreme Court ruling overturning Roe v Wade in 2022.
The aim of the order is to increase avenues for women to gain access to contraception, and to decrease costs associated, as reproductive rights advocates have been campaigning highlighting the barriers women are facing in acquiring contraception, leaving millions of women vulnerable and without contraception.
The ruling could help to encourage private health insurance agents to offer broader coverage and contraception options, such as covering multiple products and increasing efficiency in the process of obtaining appropriate care, all coming under the Affordable Care Act.
The order will also mean increased access to over the counter contraception, increase coverage of contraception through Medicare, promote family planning services through Medicaid, support access to contraception to vulnerable groups and students, and to further research and data collection on contraception access across the USA.
"This action will build on the progress already made under the Affordable Care Act by further reducing barriers that women face in accessing contraception prescribed by their provider," a White House fact sheet on the order proclaimed.
“Today’s announcements build on actions that the Biden-Harris Administration has already taken to protect access to contraception, including in response to two prior Executive Orders directing actions to safeguard access to reproductive health care services” stated the fact sheet.
In 2022, the US House of Representatives, which was largely controlled by the Democratic party at the time, passed a bill to request a law with the aim of protecting women’s access to contraception. However, on consideration by the Senate, the bill was eventually blocked from passing into law by Republican representatives.
As recently as last week, two Senators moved to introduce a new bill to achieve better protection for access to contraception, for this bill to get passed, it will need to be signed off by Democratic-controlled Senate and the Republican-controlled House.
Related News
-
News More to celebrate at the CPHI Milan Pharma Awards 2024
The CPHI Milan Pharma Awards, which are now open for nominations until 18 May 2024, celebrate the innovators making a difference. This year, two new categories have been added to further honour the contributions of a diverse range of pharma professiona... -
News Special Edition Women in Pharma: Women’s health and the pharmaceutical industry
International Women’s Day is an annual celebration of women around the world every March 8. March also marks Women’s History Month. This March, our Women in Pharma series takes a look at how women’s healthcare has developed, and the r... -
News Informa Markets International Women’s Day Panel Discussion
On March 7, 2024, the Informa Markets Amsterdam office hosted an International Women’s Day Breakfast and Panel Discussion to celebrate the women who drive the B2B events industry forward, including members of the CPHI team. -
News 5 African American Pharmaceutical Pioneers: Honouring Black History Month
In recognition of February as Black History Month in the United States, we cover the lives and works of five pioneering African American pharmaceutical professionals who have contributed significantly to the world of pharmaceuticals and drug devel... -
News Genome study discovers 275 million new variants across a diverse population
A new genome study undertaken in the US, accounting for a diverse range of people, has led to the discovery of nearly 300 million new genetic variants, which could inform markers of disease. -
News Special Edition Women in Pharma: International Day of Women and Girls in Science
In this monthly series, we bring insightful content, events, and communities dedicated to sharing best practices for DE&I strategies and showcasing underrepresented voices in the pharmaceutical community. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack 2024 - From the Floor
Paris once again welcomes Europe’s leading trade show in pharmaceutical packaging and drug delivery innovation. Join our content team as Pharmapack 2024 opens its doors to leading experts and innovators in pharmaceutical packaging and drug delive...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance